Literature DB >> 14523224

Developing a programme of transitional care for adolescents with juvenile idiopathic arthritis: results of a postal survey.

K L Shaw1, T R Southwood, J E McDonagh.   

Abstract

OBJECTIVES: To explore the transitional needs of adolescents with juvenile idiopathic arthritis (JIA), as perceived by a range of professionals, and to examine how these needs may be addressed within a structured programme of transitional care.
METHODS: Postal surveys (n = 1670) were distributed to key professionals employed in health, social support, education and vocation.
RESULTS: Surveys were completed by 478 individuals. The majority of respondents (91%) were currently active in the care of adolescents with JIA. Planning for transitional care was perceived to be important for both adolescents and parents and to require multidisciplinary involvement. Respondents rated a wide range of resources to be important in supporting adolescents, including self-medication teaching packages and social skills training. A number of barriers to providing transitional care were identified, including inadequate resources, coordination and training.
CONCLUSION: Transitional care in the context of JIA is perceived as necessary by a wide variety of professionals.

Entities:  

Mesh:

Year:  2003        PMID: 14523224     DOI: 10.1093/rheumatology/keh018

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  17 in total

1.  Why bother talking to teenagers?

Authors:  Samir Dawlatly
Journal:  Br J Gen Pract       Date:  2012-02       Impact factor: 5.386

2.  [Transition clinic--it is not always a simple segue in rheumatology for adults].

Authors:  K Minden; M Niewerth; A Zink; G Ganser
Journal:  Z Rheumatol       Date:  2005-06       Impact factor: 1.372

Review 3.  Transition of care from paediatric to adult rheumatology.

Authors:  Janet E McDonagh
Journal:  Arch Dis Child       Date:  2007-09       Impact factor: 3.791

4.  The HIV experience: youth identified barriers for transitioning from pediatric to adult care.

Authors:  Lori S Wiener; Brie-Anne Kohrt; Haven B Battles; Maryland Pao
Journal:  J Pediatr Psychol       Date:  2009-12-29

Review 5.  Juvenile idiopathic arthritis: the paediatric perspective.

Authors:  Alison Jordan; Janet E McDonagh
Journal:  Pediatr Radiol       Date:  2006-05-11

6.  Growing up and moving on. A multicentre UK audit of the transfer of adolescents with juvenile idiopathic arthritis from paediatric to adult centred care.

Authors:  L P Robertson; J E McDonagh; T R Southwood; K L Shaw
Journal:  Ann Rheum Dis       Date:  2005-06-30       Impact factor: 19.103

7.  Transfer from paediatric rheumatology to the adult rheumatology setting: experiences and expectations of young adults with juvenile idiopathic arthritis.

Authors:  Deborah Hilderson; Leen Eyckmans; Kristien Van der Elst; Rene Westhovens; Carine Wouters; Philip Moons
Journal:  Clin Rheumatol       Date:  2012-12-14       Impact factor: 2.980

8.  Lack of Knowledge and Low Readiness for Health Care Transition in Eosinophilic Esophagitis and Eosinophilic Gastroenteritis.

Authors:  Swathi Eluri; Wendy M Book; Ellyn Kodroff; Mary Jo Strobel; Jessica H Gebhart; Patricia D Jones; Paul Menard-Katcher; Maria E Ferris; Evan S Dellon
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-07       Impact factor: 2.839

Review 9.  Transition of care from paediatric to adult services in haematology.

Authors:  Paula H B Bolton-Maggs
Journal:  Arch Dis Child       Date:  2007-09       Impact factor: 3.791

10.  Consensus of the Spanish society of pediatric rheumatology for transition management from pediatric to adult care in rheumatic patients with childhood onset.

Authors:  Inmaculada Calvo; Jordi Antón; Sagrario Bustabad; Marisol Camacho; Jaime de Inocencio; M Luz Gamir; Jenaro Graña; Lucía La Cruz; Juan Carlos López Robledillo; Marta Medrano; Rosa Merino; Consuelo Modesto; Esmeralda Nuñez; M Jesús Rua; Vicenç Torrente-Segarra; Carmen Vargas; Loreto Carmona; Estíbaliz Loza
Journal:  Rheumatol Int       Date:  2015-04-28       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.